E. Artaud-Macari

Sotatercept improves echocardiographic risk stratification in pulmonary arterial hypertension: real-world data from the french early access program

Management of pulmonary arterial hypertension (PAH) is guided by multiparametric risk assessment, integrating clinical, biological, imaging, and hemodynamic parameters. Echocardiographic low-risk features include right atrial (RA) area <18 cm², TAPSE/PASP ratio >0.32 mm/mmHg, and absence of pericardial effusion....